• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据膜通透性对中分子的定义。

Middle molecule definition in terms of membrane permeability.

作者信息

Klein E

出版信息

Artif Organs. 1981;4 Suppl:46-50.

PMID:7295095
Abstract

The term "Middle Molecules" originated as an operational definition for metabolites whose removal rate in the dialyzers of the 1970s was limited principally by the devices then used. Improvements in both the device designs and membrane performance require that we reexamine the definition. This discussion presents the relationship between membrane properties and operating conditions so that a general prediction can be made for metabolite clearance using either dialysis or hemofiltration. The current theories of solute/solvent coupling during membrane transport require that the designer and user consider not only the intrinsic membrane properties, but also the ultrafiltration velocity applied during therapy. This is particularly important in the use of hemofiltration, but may also be significant when high ultrafiltration rate dialyzers are employed. To provide a working definition of middle molecules, we reference the transport of solutes of increasing hydrodynamic radius to the transport of urea. Data for a series of membranes used in current and experimental devices will be presented.

摘要

“中分子”一词最初是作为一种操作定义,用于描述20世纪70年代在透析器中清除率主要受当时使用的设备限制的代谢物。设备设计和膜性能的改进要求我们重新审视这一定义。本讨论阐述了膜特性与操作条件之间的关系,以便能够对使用透析或血液滤过的代谢物清除率进行总体预测。当前关于膜转运过程中溶质/溶剂耦合的理论要求设计者和使用者不仅要考虑膜的固有特性,还要考虑治疗过程中施加的超滤速度。这在血液滤过的应用中尤为重要,但在使用高超滤率透析器时也可能很重要。为了给出中分子的实用定义,我们将增加流体动力学半径的溶质的转运与尿素的转运进行了对比。将给出当前和实验设备中使用的一系列膜的数据。

相似文献

1
Middle molecule definition in terms of membrane permeability.根据膜通透性对中分子的定义。
Artif Organs. 1981;4 Suppl:46-50.
2
Blood flow, ultrafiltration and solute transport rate in continuous arteriovenous haemodiafiltration: the AN-69 flat-plate haemofilter.持续动静脉血液透析滤过中的血流、超滤及溶质转运率:AN - 69平板血液滤过器
Nephrol Dial Transplant. 1992;7(1):29-34.
3
Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.双滤过人工肾中小分子、中分子和大分子物质的转运
Artif Organs. 1981;4 Suppl:104-9.
4
An overview of clinical implications of middle molecules and their kinetics in uremia.尿毒症中分子物质的临床意义及其动力学概述
Artif Organs. 1981;4 Suppl:125-32.
5
[Uremic middle-molecule toxins and their removal in hemofiltration].[尿毒症中分子毒素及其在血液滤过中的清除]
Urol Nefrol (Mosk). 1991 Jan-Feb(1):67-73.
6
Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.低透析液流速下小溶质的透析器清除率和传质面积系数。
ASAIO J. 2006 Jul-Aug;52(4):404-9. doi: 10.1097/01.mat.0000227687.88929.08.
7
Methodology for identification of serum middle molecules.血清中分子的鉴定方法。
Artif Organs. 1981;4 Suppl:22-7.
8
Serum middle molecules in uremia.尿毒症患者的血清中分子物质
Artif Organs. 1981;4 Suppl:143-50.
9
Extracorporeal strategies for the removal of middle molecules.用于清除中分子物质的体外策略。
Semin Dial. 2006 Mar-Apr;19(2):110-4. doi: 10.1111/j.1525-139X.2006.00135.x.
10
Solute transport across the peritoneal membrane.溶质通过腹膜的转运。
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S84-91.